Next Choice
Product Images NDC 21695-443

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Next Choice (NDC 21695-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (443)

NEXT CHOICE 0.75mg tablets bottle label showing product NDC 21695-443-02 by Rebel Distributors Corp. The label states each tablet contains levonorgestrel 0.75mg, with a quantity of 2 tablets per container. Additional labeling includes product ID RH044302 and distribution details for Physician Partners in Thousand Oaks, California.*

FDA Label Image

4e0a71e2-figure-01 (4e0a71e2 Figure 01)

The image shows a warning text panel for Levonorgestrel Tablets, 0.75 mg, issued in June 2009. It states the product is Rx only, intended for women age 17 and younger, and is not approved for nonprescription use.*

FDA Label Image

4e0a71e2-figure-02 (4e0a71e2 Figure 02)

Chemical structure diagram of the active ingredient in NEXT CHOICE by Rebel Distributors Corp. The structure shows a steroidal framework with hydroxyl and ketone functional groups and an alkyne side chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.